(September 4, 2018, 10:49 AM EDT) -- BOSTON — A U.S. attorney on Aug. 21 told seven Insys Therapeutics Inc. defendants that the government intends to file a second superseding indictment against them for their alleged roles in the off-label promotion of Subsys, a spray form of fentanyl (United States v. Michael L. Babich, et al., No. 16-cr-10343, D. Mass.)....